Mandatory Partners with NuORDER by Lightspeed to Redefine Market Connections, Announces Digital Trade Show Event
17.12.2024 08:02:00 CET | Business Wire | Press Release
Recognizing the geographical limitations of physical shows, Mandatory has taken a bold step forward by partnering with NuORDER by Lightspeed, a leading global B2B commerce platform, to offer a digital trade show that will run in tandem with its next in-person event taking place in Copenhagen January 28-30, 2025.
With buyers traveling less and carefully selecting events, Mandatory is reshaping the way the industry operates. By providing a focused platform where brands and buyers can connect effectively, Mandatory emphasizes specificity, integrity, and a waterproof storytelling approach to stand out in the competitive market.
“The post-pandemic retail landscape has shifted,” said Mads Petersen, of Mandatory. “Consumers are more knowledgeable than ever, and retailers face a smaller, more challenging landscape. Now more than ever, collaboration between retailers and brands is critical to create strong, sustainable relationships that drive long-term success.”
Innovative Collaboration with NuORDER
The digital trade show with NuORDER by Lightspeed will provide an opportunity for brands to share a preview of their collections ahead of the event and connect with international buyers not in attendance. NuORDER’s cutting-edge technology breaks down outdated barriers within the industry, creating new opportunities for brands and retailers around the world to discover each other and strengthen their businesses.
“As a brand, being able to receive orders year-round without the limitations of geography is a game-changer,” said MajLa Pizzelli, Founder and CEO of ATP Atelier. “NuORDER’s platform allows us to showcase our collections to the right buyers anytime, anywhere, extending our reach and streamlining our processes. It’s a level of convenience and efficiency we’ve never experienced before.”
Commenting on the partnership, Clara Leone, Co-owner of Mandatory, emphasized the critical role of human connection in leveraging technology: “In challenging times, it’s more important than ever to blend human values, personal relationships, and authenticity with technology. NuORDER allows us to combine the efficiency of digital tools with the warmth and trust that only personal connections can bring, creating a one-of-a-kind community where connections and businesses grow and thrive together.”
In addition to partnering on the launch of the digital trade show, buyers including Rinascente Peek and Cloppenburg, Illum, Highsnobiety and Slam Jam, who are part of the NuORDER by Lightspeed network, will be attending the in-person tradeshow. This initiative demonstrates Mandatory’s commitment to creating new opportunities for brands and buyers alike to build new relationships and expand their global footprints.
“Mandatory and NuORDER together represent the future of industry connectivity,” added Chris Akrimi, Head of B2B at Lightspeed. “We aim to provide a 360-degree partnership for brands, helping them connect with relevant buyers globally. This integration sets new standards for collaboration, ensuring that brands and retailers can expand their networks, grow their businesses, and deepen their partnerships.”
A New Era of Regional Industry Events
Mandatory is committed to hosting innovative, industry-changing regional events that redefine how contemporary brands interact with the market. By merging NuORDER’s technological prowess with Mandatory’s vision, the partnership lays a foundation for a stronger, more connected future for the industry.
For media inquiries, interviews, or more information about upcoming events, please contact:
Clara Leone
Mandatory
0045 2256 7474
clara@mandatorycph.com
About Mandatory
Mandatory is a contemporary mid-high-end market platform dedicated to fostering strong, sustainable relationships between brands and buyers. With a focus on clarity, integrity, and strategic partnerships, Mandatory is redefining how the industry operates in a competitive landscape.
About NuORDER by Lightspeed
NuORDER by Lightspeed is a leading B2B commerce platform powering wholesale buying and selling. NuORDER offers a full suite of commerce solutions engineered to streamline the way brands sell their products all around the world while providing retailers with the insights they need to make better buying decisions. Today, more than 3,000 brands and more than 100,000 retailers use NuORDER to transform their wholesale operations. Lightspeed acquired NuORDER in 2021.
Powering the businesses that are the backbone of the global economy, Lightspeed's one-stop commerce platform helps merchants innovate to simplify, scale, and provide exceptional customer experiences. Lightspeed's cloud commerce solution transforms and unifies online and physical operations, multichannel sales, expansion to new locations, global payments, financial solutions, and connection to supplier networks.
Founded in Montréal, Canada in 2005, Lightspeed is dual-listed on the New York Stock Exchange (NYSE: LSPD) and Toronto Stock Exchange (TSX: LSPD). With teams across North America, Europe, and Asia Pacific, the company serves retail, hospitality, and golf businesses in over 100 countries.
Forward-Looking Statements
This news release may include forward-looking information and forward-looking statements within the meaning of applicable securities laws ("forward-looking statements"), including information related to Lightspeed’s products and partnerships. Forward-looking statements are statements that are predictive in nature, depend upon or refer to future events or conditions and are identified by words such as "will", "expects", "anticipates", "intends", "plans", "believes", "estimates" or similar expressions concerning matters that are not historical facts. Such statements are based on current expectations of Lightspeed's management and inherently involve numerous risks and uncertainties, known and unknown, including economic factors. A number of risks, uncertainties and other factors may cause actual results to differ materially from the forward-looking statements contained in this news release, including, among other factors, those risk factors identified in our most recent Management's Discussion and Analysis of Financial Condition and Results of Operations, under "Risk Factors" in our most recent Annual Information Form, and in our other filings with the Canadian securities regulatory authorities and the U.S. Securities and Exchange Commission, all of which are available under our profiles on SEDAR+ at www.sedarplus.com and on EDGAR at www.sec.gov. Readers are cautioned to consider these and other factors carefully when making decisions with respect to Lightspeed's subordinate voting shares and not to place undue reliance on forward-looking statements. Forward-looking statements contained in this news release are not guarantees of future performance and, while forward-looking statements are based on certain assumptions that Lightspeed considers reasonable, actual events and results could differ materially from those expressed or implied by forward-looking statements made by Lightspeed. Except as may be expressly required by applicable law, Lightspeed does not undertake any obligation to update publicly or revise any such forward-looking statements, whether as a result of new information, future events or otherwise.
View source version on businesswire.com: https://www.businesswire.com/news/home/20241216009247/en/
Contacts
For further information:
NuORDER by Lightspeed Media Relations
Laura Baumgartner, VP Asylum Public Relations
lbaumgartner@asylumpr.com
(c) 2024 Business Wire, Inc., All rights reserved.
Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Barilla Opens Global Call for Startups Through Good Food Makers 202625.5.2026 11:47:00 CEST | Press Release
Barilla Group has opened applications for the 2026 edition of Good Food Makers, its global open innovation program designed to co-develop and test new innovative solutions with startups and innovators inside real industrial environments. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260521973445/en/ Since its launch in 2019, the program has involved more than 1,100 startups from over 50 countries, leading to 26 pilot projects, with over 20 projects currently active thanks to the solutions developed by the program’s alumni. This highlights the program’s role as a concrete platform for industrial scalable innovation. The 2026 edition comes at a pivotal moment for the company, following the launch of BITE (Barilla Innovation & Technology Experience), the new innovation center dedicated to developing the next generation of food products. Within this inspiring premise, Good Food Makers confirms itself as one of the main levers f
JEOL: Sales Launch of the Laser SEM System “LazEdge”25.5.2026 10:16:00 CEST | Press Release
JEOL Ltd. (President & CEO: Izumi Oi) has developed the “LazEdge”, an SEM system equipped with a laser processing system, and begins sales on May 25, 2026. Cross-section preparation instruments such as the focused ion beam system (FIB system), are widely used in science and technology fields across research institutes, universities, and industries. In recent years, demand is increasing for a system that can process large-areas at a high speed, while achieving high-quality of the processed surface. “LazEdge” is an instrument integrating JEOL’s SEM with the laser technology proprietary of Hamamatsu Photonics K.K., and enables laser processing inside the specimen chamber of the electron microscope. This system enables high-quality cross-section specimens produced through high-speed, large-area processing to be transferred seamlessly to subsequent analyses, such as SEM observation, elemental analysis, and crystal orientation analysis, without exposure to the external environment. As a resu
TFG-001, A Novel 3D Neural Microtissue Cell Therapy, Demonstrates Superior Functionality and Reinnervation for Parkinson’s Disease25.5.2026 08:00:00 CEST | Press Release
TreeFrog Therapeutics, a regenerative medicine biotech company developing next-generation cell therapies, today announced that it will present new preclinical data on TFG-001 at the 7th World Parkinson’s Conference. TFG-001, a 3D neural microtissue cell therapy, demonstrated rapid dopamine release and extensive graft-derived reinnervation across multiple advanced translational Parkinson’s disease models—supporting its potential as a best-in-class candidate. The critical need for reinnervation in Parkinson's disease In Parkinson's disease, an estimated 60–80% of dopaminergic neurons are already lost before motor symptoms even appear. The nigrostriatal pathway degenerates, destroying the essential wiring that connects dopamine-producing neurons to movement control. While chemical dopamine replacements (like levodopa) can manage symptoms, they cannot restore the spatial precision, feedback loops, or dynamic regulation of a healthy brain network. To achieve true functional restoration, it
Galderma Receives U.S. FDA Approval for Differin ® Epiduo ® Acne Gel Prescription-to-OTC Switch22.5.2026 18:25:00 CEST | Press Release
Galderma (SIX: GALD), the pure-play dermatology category leader, today announced that the United States (U.S.) Food and Drug Administration (FDA) has approved Differin® Epiduo® Acne Gel (Adapalene 0.1% and Benzoyl Peroxide 2.5% Acne Treatment) for over-the-counter (OTC) use in ages 12 years and older, marking a significant Prescription-to-OTC transition in acne care. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260522074280/en/ The U.S. FDA approves Differin® Epiduo® Acne Gel Prescription-to-OTC switch This milestone represents yet another example of Galderma’s unique Integrated Dermatology strategy, demonstrating how proven innovations from its Therapeutic Dermatology portfolio can further strengthen its Dermatological Skincare offerings. The Prescription‑to‑OTC transition highlights Galderma’s scale and expertise in successfully commercializing dermatology innovations across the full spectrum of acne care. With the appro
Avanzanite Bioscience’s Partner Agios Announces PYRUKYND® (mitapivat) Approval in the European Union for Adults with Thalassaemia22.5.2026 16:18:00 CEST | Press Release
Avanzanite Bioscience B.V., a rapidly growing commercial-stage European specialty pharmaceutical company focused on rare diseases, today reported that its partner, Agios Pharmaceuticals, Inc. (Nasdaq: AGIO), a commercial-stage biopharmaceutical company headquartered in Cambridge, Massachusetts focused on delivering innovative medicines for patients with rare diseases, announced that the European Commission has granted marketing authorisation for PYRUKYND® (mitapivat), an oral pyruvate kinase (PK) activator, in adults for the treatment of anaemia associated with transfusion-dependent and non-transfusion-dependent alpha- or beta-thalassaemia, with an orphan medicinal product designation. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260522186975/en/ Adam Plich, CEO and Co-Founder of Avanzanite Bioscience. “Thalassaemia is a complex, chronic and multisystem disease characterised by anaemia, ineffective erythropoiesis and haemo
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom